日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy

抗血管内皮生长因子治疗对房水白细胞介素-6和视力结果的影响

Sepah, Yasir Jamal; Do, Diana V; Mesquida, Marina; Day, Bann-Mo; Blotner, Steven; Afridi, Rubbia; Halim, Muhammad Sohail; Hong, Kyu; Wakshull, Eric; Fauser, Sascha; Stoilov, Ivaylo; Dong Nguyen, Quan

Assessing Real-World Racial Differences Among Patients With Metastatic Triple-Negative Breast Cancer in US Community Practices

评估美国社区医疗机构中转移性三阴性乳腺癌患者的真实种族差异

Tan, Ruoding; Cassoli, Lourenia; Yan, Ying; Shen, Vincent; Day, Bann-Mo; Mitchell, Edith P

Disease-modifying effects of ranibizumab for central retinal vein occlusion

雷珠单抗对中心性视网膜静脉阻塞的疾病改善作用

Huang, Jason M; Khurana, Rahul N; Ghanekar, Avanti; Wang, Pin-Wen; Day, Bann-Mo; Blodi, Barbara A; Domalpally, Amitha; Quezada-Ruiz, Carlos; Ip, Michael S

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer

恩曲替尼治疗局部晚期或转移性ROS1融合阳性非小细胞肺癌的疗效和安全性最新综合分析

Dziadziuszko, Rafal; Krebs, Matthew G; De Braud, Filippo; Siena, Salvatore; Drilon, Alexander; Doebele, Robert C; Patel, Manish R; Cho, Byoung Chul; Liu, Stephen V; Ahn, Myung-Ju; Chiu, Chao-Hua; Farago, Anna F; Lin, Chia-Chi; Karapetis, Christos S; Li, Yu-Chung; Day, Bann-Mo; Chen, David; Wilson, Timothy R; Barlesi, Fabrice

Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis

吡非尼酮可降低特发性肺纤维化患者的呼吸系统相关住院率

Ley, Brett; Swigris, Jeffrey; Day, Bann-Mo; Stauffer, John L; Raimundo, Karina; Chou, Willis; Collard, Harold R

BRAF(V600) mutations in solid tumors, other than metastatic melanoma and papillary thyroid cancer, or multiple myeloma: a screening study

除转移性黑色素瘤、乳头状甲状腺癌或多发性骨髓瘤以外的实体瘤中BRAF(V600)突变:一项筛查研究

Cohn, Allen L; Day, Bann-Mo; Abhyankar, Sarang; McKenna, Edward; Riehl, Todd; Puzanov, Igor

Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States

美国男性和女性滤泡性淋巴瘤患者的疾病、治疗和预后差异

Nabhan, Chadi; Zhou, Xiaolei; Day, Bann-Mo; Dawson, Keith; Zelenetz, Andrew D; Friedberg, Jonathan W; Cerhan, James R; Link, Brian K; Flowers, Christopher R

Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials

维莫德吉治疗基底细胞癌痣综合征患者的安全性和有效性:两项试验的汇总分析

Chang, Anne Lynn S; Arron, Sarah T; Migden, Michael R; Solomon, James A; Yoo, Simon; Day, Bann-Mo; McKenna, Edward F; Sekulic, Aleksandar

Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma

维莫德吉治疗≥65岁晚期基底细胞癌患者的安全性和有效性

Chang, Anne Lynn S; Lewis, Karl D; Arron, Sarah T; Migden, Michael R; Solomon, James A; Yoo, Simon; Day, Bann-Mo; McKenna, Edward F; Sekulic, Aleksandar

A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United States

一项在美国开展的单臂、开放标签、扩大用药研究,旨在评估维莫非尼治疗转移性黑色素瘤患者的疗效。

Flaherty, Lawrence; Hamid, Omid; Linette, Gerald; Schuchter, Lynn; Hallmeyer, Sigrun; Gonzalez, Rene; Cowey, C Lance; Pavlick, Anna; Kudrik, Fred; Curti, Brendan; Lawson, David; Chapman, Paul B; Margolin, Kim; Ribas, Antoni; McDermott, David; Flaherty, Keith; Cranmer, Lee; Hodi, F Stephen; Day, Bann-Mo; Linke, Rolf; Hainsworth, John